Zobrazeno 1 - 10
of 764
pro vyhledávání: '"K, Altman"'
Autor:
Alexander E. Perl, Naoko Hosono, Pau Montesinos, Nikolai Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C. Smith, Mark J. Levis, Stephen Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je-Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V. Tiu, Jessica K. Altman
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-9 (2022)
Abstract The fms-like tyrosine kinase 3 (FLT3) inhibitor gilteritinib is indicated for relapsed or refractory (R/R) FLT3-mutated acute myeloid leukemia (AML), based on its observed superior response and survival outcomes compared with salvage chemoth
Externí odkaz:
https://doaj.org/article/177517e470014866a24e2133dc705fd7
Autor:
Yang Mei, Kehan Ren, Yijie Liu, Annabel Ma, Zongjun Xia, Xu Han, Ermin Li, Hamza Tariq, Haiyan Bao, Xinshu Xie, Cheng Zou, Dingxiao Zhang, Zhaofeng Li, Lili Dong, Amit Verma, Xinyan Lu, Yasmin Abaza, Jessica K. Altman, Madina Sukhanova, Jing Yang, Peng Ji
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 17 (2022)
Myelodysplastic syndromes (MDS) are age-related myeloid neoplasms with increased risk of progression to acute myeloid leukemia (AML). The mechanisms of transformation of MDS to AML are poorly understood, especially in relation to the aging microenvir
Externí odkaz:
https://doaj.org/article/f52fc2be4cd74c139752de52924f4425
Autor:
Jessica K. Altman, Alexander E. Perl, Jason E. Hill, Matt Rosales, Erkut Bahceci, Mark J. Levis
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 797-805 (2021)
Abstract The FLT3 inhibitor gilteritinib has clinical activity in patients with FLT3‐mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML). The impact of FLT3 mutation clearance and the achievement of composite complete remissio
Externí odkaz:
https://doaj.org/article/92baa7142e5241629a9ffee6b3b2ff12
Autor:
Adrian M. Wong, Tushar P. Patel, Elizabeth K. Altman, Nicol Tugarinov, Giampaolo Trivellin, Jack A. Yanovski
Publikováno v:
Adipocyte, Vol 10, Iss 1, Pp 21-27 (2021)
The Tg(Adipoq-cre)1Evdr mouse has become an important tool in adipose tissue biology. However, the exact genomic transgene integration site has not been established. Using Targeted Locus Amplification (TLA) we found the transgene had integrated on mo
Externí odkaz:
https://doaj.org/article/a19e4e67404a4a9c8a251bd866f4b0ca
Autor:
Sumithira Vasu, Jessica K. Altman, Geoffrey L. Uy, Martin S. Tallman, Ivana Gojo, Gerard Lozanski, Ute Burkard, Annika Osswald, Pamela James, Björn Rüter, William Blum
Publikováno v:
Haematologica, Vol 107, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/da599416e7f6473b976ba96c5e456a6a
Publikováno v:
HemaSphere, Vol 6, Pp 392-393 (2022)
Externí odkaz:
https://doaj.org/article/2f8b2adaafad4c808aa6b15fa3902c54
Autor:
Dawn M. Ehde, Kevin N. Alschuler, Melissa A. Day, Marcia A. Ciol, Makena L. Kaylor, Jennifer K. Altman, Mark P. Jensen
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background Chronic pain is one of the most prevalent and disabling symptoms associated with multiple sclerosis (MS). Individuals with MS are interested in nonpharmacologic pain management approaches. Cognitive-behavioral therapy (CBT) is eff
Externí odkaz:
https://doaj.org/article/ca082c3edf614b61a415b37fe31ffb99
Autor:
Haiyan Bao, Juehua Gao, Yi-Hua Chen, Jessica K. Altman, Olga Frankfurt, Amanda L. Wilson, Madina Sukhanova, Qing Chen, Xinyan Lu
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Backgroud Myeloid sarcoma (MS) is a rare neoplasm of immature myeloid precursors that form tumor mass outside the bone marrow. The diagnosis of de novo MS can be challenging, particularly in patients with no prior history of hematologic mali
Externí odkaz:
https://doaj.org/article/96f799de4ddf416ea1265b32a0ae7693
Autor:
Daniel A. Pollyea, Jessica K. Altman, Rita Assi, Dale Bixby, Amir T. Fathi, James M. Foran, Ivana Gojo, Aric C. Hall, Brian A. Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori Maness, James Mangan, Gabriel Mannis, Guido Marcucci, Alice Mims, Kelsey Moriarty, Moaath Mustafa Ali, Jadee Neff, Reza Nejati, Rebecca Olin, Mary-Elizabeth Percival, Alexander Perl, Amanda Przespolewski, Dinesh Rao, Farhad Ravandi, Rory Shallis, Paul J. Shami, Eytan Stein, Richard M. Stone, Kendra Sweet, Swapna Thota, Geoffrey Uy, Pankit Vachhani, Carly J. Cassara, Deborah A. Freedman-Cass, Katie Stehman
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:503-513
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2bfdc5ec6e73de65bd498c0aa50af4b
https://doi.org/10.6004/jnccn.2023.0025
https://doi.org/10.6004/jnccn.2023.0025
Autor:
Guillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, Jessica K Altman, Amir T Fathi, Olatoyosi Odenike, Gail J Roboz, Kendra Sweet, Crystal Miller, Anders Wennborg, Denice K Hickman, Rashmi Kanagal-Shamanna, Hagop Kantarjian, Jeffrey Lancet, Rami Komrokji, Eyal C Attar, David A Sallman
Publikováno v:
The Lancet Haematology. 10:e272-e283
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::498956c3047927105c5def6de0594920
https://doi.org/10.1016/s2352-3026(22)00403-3
https://doi.org/10.1016/s2352-3026(22)00403-3